Similar articles

• The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.

  Bloomfield CD, Gajl-Peczalska KJ. Bloomfield CD, et al. Curr Top Hematol. 1980;3:175-240. Curr Top Hematol. 1980. PMID: 6276102 Review. No abstract available.
• Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.

  Aisenberg AC. Aisenberg AC. N Engl J Med. 1981 Feb 5;304(6):331-6. doi: 10.1056/NEJM198102053040606. N Engl J Med. 1981. PMID: 6969365 No abstract available.
• Lymphocyte surface markers in human disease.

  Townes AS, Postlethwaite AE. Townes AS, et al. Adv Intern Med. 1977;22:97-119. Adv Intern Med. 1977. PMID: 320850 Review. No abstract available.
• Immunologic basis for the redefinition of malignant lymphomas.

  Parker JW. Parker JW. Am J Clin Pathol. 1979 Oct;72(4 Suppl):670-86. Am J Clin Pathol. 1979. PMID: 386778
• [Immunologic diagnosis of variants of chronic lymphoid leukemia and lymphosarcomas].

  Samoĭlova RS, Ol'shevskaia EV, Polianskaia AM. Samoĭlova RS, et al. Ter Arkh. 1981;53(11):73-8. Ter Arkh. 1981. PMID: 7041315 Russian. No abstract available.